Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -2.07%5.39B | 11.72%3.74B | 95.33%2.82B | 6.94%7.09B | 26.59%5.5B | 44.09%3.35B | 26.14%1.44B | 27.37%6.63B | 9.01%4.34B | -17.48%2.32B |
| Operating income | -2.07%5.39B | 11.72%3.74B | 95.33%2.82B | 6.94%7.09B | 26.59%5.5B | 44.09%3.35B | 26.14%1.44B | 27.37%6.63B | 9.01%4.34B | -17.48%2.32B |
| Cost of sales | ---- | -16.39%-2.37B | ---- | -15.79%-4.68B | ---- | -103.71%-2.03B | ---- | -35.30%-4.04B | ---- | 43.93%-998.64M |
| Operating expenses | 8.43%-3.16B | -16.39%-2.37B | -182.89%-2.04B | -15.79%-4.68B | -49.57%-3.46B | -103.71%-2.03B | -70.37%-721.66M | -35.30%-4.04B | -4.65%-2.31B | 43.93%-998.64M |
| Gross profit | 8.69%2.22B | 4.50%1.37B | 7.90%779.85M | -6.83%2.42B | 0.49%2.04B | -0.83%1.31B | 0.17%722.73M | 16.72%2.59B | 14.42%2.03B | 28.01%1.33B |
| Administrative expenses | -7.60%-136.58M | -11.38%-86.75M | -29.35%-45.99M | -4.33%-191.54M | -7.49%-126.94M | -6.54%-77.89M | 6.38%-35.56M | -13.10%-183.58M | -6.22%-118.09M | -5.41%-73.11M |
| Profit from asset sales | 86.02%-214.82K | ---- | ---- | ---- | -55.38%-1.54M | ---- | ---- | ---- | -1,021.94%-988.99K | ---- |
| Revaluation surplus | 702.08%31.98M | ---- | 11.97%34.93M | ---- | 85.98%-5.31M | ---- | 285.44%31.2M | ---- | -2,510.19%-37.89M | ---- |
| -Changes in the fair value of other assets | 702.08%31.98M | ---- | 11.97%34.93M | ---- | 85.98%-5.31M | ---- | 285.44%31.2M | ---- | -2,510.19%-37.89M | ---- |
| Impairment and provision | -3,241.76%-4.06M | -3,084.38%-3.06M | ---- | 144.78%176K | -2.04%-121.61K | 19.33%-96K | ---- | -211.90%-393K | -209.02%-119.18K | -209.17%-119K |
| -Other impairment is provision | -3,241.76%-4.06M | -3,084.38%-3.06M | ---- | 144.78%176K | -2.04%-121.61K | 19.33%-96K | ---- | -211.90%-393K | -209.02%-119.18K | -209.17%-119K |
| Special items of operating profit | 61.99%69.82M | 38.85%122.27M | 10.61%17.11M | 179.41%165.39M | -23.92%43.1M | 431.28%88.05M | 88.45%15.47M | -56.11%59.19M | 20.61%56.65M | -75.09%16.57M |
| Operating profit | 11.79%2.15B | 6.15%1.41B | 7.07%775.96M | -3.17%2.39B | 0.53%1.93B | 4.39%1.32B | 8.19%724.72M | 12.50%2.47B | 13.24%1.92B | 22.86%1.27B |
| Financing cost | -207.40%-158.89M | -41.43%-138.14M | -134.67%-29.19M | 18.32%-174.49M | 33.19%-51.69M | 8.06%-97.67M | 39.80%-12.44M | 5.69%-213.63M | 31.34%-77.37M | 10.01%-106.23M |
| Share of profits of associates | ---- | 27.02%11.01M | ---- | 23.71%10.63M | ---- | 8.35%8.67M | ---- | -11.68%8.6M | ---- | -2.37%8M |
| Adjustment items of earning before tax | -82.28%534.73K | ---- | 37.22%135.14K | ---- | -34.35%3.02M | ---- | 178.99%98.48K | ---- | 597.84%4.6M | ---- |
| Earning before tax | 6.26%1.99B | 3.51%1.28B | 4.85%746.91M | -1.64%2.23B | 1.86%1.88B | 5.55%1.24B | 9.73%712.38M | 14.46%2.26B | 16.78%1.84B | 26.84%1.17B |
| Tax | -7.84%-492.45M | -3.56%-309.99M | -10.80%-192.09M | 9.29%-533.07M | -0.92%-456.66M | 3.25%-299.34M | -1.66%-173.38M | -4.53%-587.66M | -5.93%-452.52M | -12.36%-309.41M |
| After-tax profit from continuing operations | 5.75%1.5B | 3.50%968.64M | 2.93%554.81M | 1.05%1.69B | 2.16%1.42B | 8.71%935.92M | 12.60%539.01M | 18.40%1.68B | 20.81%1.39B | 33.01%860.91M |
| Earning after tax | 5.75%1.5B | 3.50%968.64M | 2.93%554.81M | 1.05%1.69B | 2.16%1.42B | 8.71%935.92M | 12.60%539.01M | 18.40%1.68B | 20.81%1.39B | 33.01%860.91M |
| Minority profit | 28.93%25.06M | -43.33%7.24M | -75.70%3.66M | 24.94%23.04M | -51.12%19.44M | -43.25%12.78M | -21.54%15.07M | 161.81%18.44M | 278.44%39.77M | 211.22%22.52M |
| Profit attributable to shareholders | 5.43%1.48B | 4.14%961.4M | 5.19%551.15M | 0.78%1.67B | 3.73%1.4B | 10.11%923.14M | 14.03%523.94M | 14.69%1.66B | 15.13%1.35B | 25.60%838.4M |
| Basic earnings per share | 4.13%0.8797 | 3.77%0.5776 | 5.19%0.3323 | 0.78%1.0073 | 3.73%0.8448 | 10.11%0.5566 | 14.04%0.3159 | 14.69%0.9995 | 15.13%0.8144 | 25.59%0.5055 |
| Diluted earnings per share | 4.13%0.8797 | 3.77%0.5776 | 5.19%0.3323 | 0.78%1.0073 | 3.73%0.8448 | 10.11%0.5566 | 14.04%0.3159 | 14.69%0.9995 | 15.13%0.8144 | 25.59%0.5055 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Hua Ming Certified Public Accountants (Special General Partnership), Ernst & Young Accounting Firm | -- | -- | -- | Ernst & Young Huaming (Special General Partnership), Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.